High Risk of Relapse with Intermediate Dose Cytarabine for Consolidation in Young Favorable Risk AML Patients Following Induction with 7+ 3

Bhaskar C Kolla; NAA Halim; Daniel J Weisdorf; Fiona He

High Risk of Relapse with Intermediate Dose Cytarabine for Consolidation in Young Favorable Risk AML Patients Following Induction with 7+ 3

Bhaskar C Kolla, NAA Halim, Daniel J Weisdorf, Fiona He

Medicine - Hematology, Oncology, Transplant

Research output: Contribution to conference › Abstract › peer-review

Original language	English (US)
State	Published - Nov 13 2019

Keywords

OpenUrl availability

Full text

Cite this

@conference{1c4b9ef3aa4d4fc197dfec4de8c3a70f,

title = "High Risk of Relapse with Intermediate Dose Cytarabine for Consolidation in Young Favorable Risk AML Patients Following Induction with 7+ 3",

keywords = "AML",

author = "Kolla, {Bhaskar C} and NAA Halim and Weisdorf, {Daniel J} and Fiona He",

year = "2019",

month = nov,

day = "13",

language = "English (US)",

}